Starting in 2015, the Medical Imaging Multimodality Breast Cancer Diagnosis User Interface (MIMBCD-UI) initiative involves the collaborative effort of three Portuguese Research Institutions: ISR, ITI and INESC-ID. The three laboratories are Associate Laboratories of IST from ULisboa - Portugal (EU). The MIMBCD-UI initiative is the precursor of both MIDA and BreastScreening initiatives. In 2022, the team was funded by a national FCT project, namely Multiple Instance Attention Learning for Multimodal Breast Cancer (MIA-BREAST) with the FCT reference 2022.04485.PTDC
(DOI: https://doi.org/10.54499/2022.04485.PTDC), receiving contributions from the MIMBCD-UI initiative. Additionally, this initiative was an important part of the BreastScreening-AI endeavor developments, a spinoff from IST. For further information, follow the public wiki of the MIMBCD-UI initiative. Moreover, we also provide a private wiki on the meta-private
repository for team usage. Unfortunately, you need to be a member of our team to access the restricted information.
Medical Imaging Multimodality Breast Cancer Diagnosis User Interface
Pinned Loading
Repositories
- prototype-multi-modality Public
✨ [AVI 2020] A prototype platform for lesion annotations and manual segmentation on breast cancer diagnosis with a multimodality strategy. The work was presented in the Advanced Visual Interfaces (AVI) conference.
MIMBCD-UI/prototype-multi-modality’s past year of commit activity - prototype-assertive-proactive Public
📈 [CHI 2023] UTA11: Prototype of the assertive and proactive trial for the Assertiveness-based BreastScreening-AI condition.
MIMBCD-UI/prototype-assertive-proactive’s past year of commit activity - prototype-assertive-reactive Public
📈 [CHI 2023] UTA11: Prototype of the assertive and reactive trial for the Assertiveness-based BreastScreening-AI condition.
MIMBCD-UI/prototype-assertive-reactive’s past year of commit activity - prototype-non-assertive-proactive Public
📈 [CHI 2023] UTA11: Prototype of the non-assertive and proactive trial for the Assertiveness-based BreastScreening-AI condition.
MIMBCD-UI/prototype-non-assertive-proactive’s past year of commit activity - prototype-non-assertive-reactive Public
📈 [CHI 2023] UTA11: Prototype of the non-assertive and reactive trial for the Assertiveness-based BreastScreening-AI condition.
MIMBCD-UI/prototype-non-assertive-reactive’s past year of commit activity - prototype-multi-modality-assistant Public archive
An assistant prototype for breast cancer diagnosis prepared with a multimodality strategy.
MIMBCD-UI/prototype-multi-modality-assistant’s past year of commit activity